Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide

Clinical trial NCT06657209 · RECRUITING

Trial details

NCT number: NCT06657209
Sponsor: Stanford University
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2 Diabetes Type 2 Diabetes Pre Diabetes

Start date: 2025-01-13
Primary completion: 2027-12-15
Enrollment: 104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.